 |
Editor's Note: Michael Robinson, a 35-year Silicon Valley veteran, is here today to show you what he believes will be the most disruptive medical technology of the decade. Its lifesaving abilities are pretty mind-boggling - but so is its profit potential. Take a look for yourself...
A Cash Blowout Could Be on the Horizon (You Can Be at the Forefront)
Dear Profit Alerts Member,
We've recently come across a new medical breakthrough with "superhuman" healing powers...
One that could soon take both the medical and financial worlds by storm.
And you can lock in a ground-floor opportunity before it hits...
Because we have details on the ONLY biotech firm with the FDA's approval.
(Learn how you can access those details by clicking here.)
 This tiny company is sitting at the cusp of a potential billion-dollar breakthrough that could very well push its stock price to double or even triple digits.
But right now, it's trading for a mere $6.
That's basically pocket change!
Mark my words - I believe that every hospital in the world (all 16,500 of them) will soon be trying to get their hands on this "miracle blood."
Luckily, you can be sitting on a pretty penny when the frenzy ensues.
See how you can get ahead of the crowd now.
Sincerely,
Michael Robinson
Director of Technology and Venture Capital Research, Money Morning
P.S. On September 30, the FDA is expected to make a major announcement... one that could launch this technology across America - and send that tiny company I told you about into the stratosphere. To learn how you can lock in your ground-floor opportunity immediately, click here.
|
To unsubscribe from Money Morning Profit Alerts emails click here.
© 2019 Money Morning All Rights Reserved.
Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice.
We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any recommendations in this letter should be made only after consulting with your financial adviser and only after reviewing the prospectus or financial statements of the company.
Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Money Morning. 1125 N Charles Street, Baltimore MD 21201.
To read our privacy policy click here. To contact Customer Service click here.
|
|
